2002, ER, Individual and Patients

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2002

Individual

Patients

How to discuss stopping screening: Mara Schonberg

GeriPal

JUNE 23, 2022

And so all of my work has really been trying to help patients understand what matters to them or make decisions based on what is likely the realistic outcomes of a decision and try to explain it to them in a way that they can understand so that they can make the best choice for them. Do you think most patients know that? Mara: Yeah.

Screening

Screening PCP PCP IT

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

SEPTEMBER 6, 2021

Typically, generic sponsors carve out a patent-protected indication or patient population, but technically, any method of use can be carved out as long as FDA determines that the product can still be used safely and effectively without the patent-protected information.

IT Provider ER Insurance

Primary Care Digest

How to discuss stopping screening: Mara Schonberg

Ding Dong is the Skinny Label (Effectively) Dead?

Stay Connected